Pioneering beyond business

An innovative medicine alone does not make people healthy. Rather, a functioning healthcare system is a task that the economy and society can only successfully manage together. This calls for well-trained doctors, competent government agencies, a fair health insurance system, informed patients, and much more. Across sectors, it is also the pioneers who can make a difference. They experience Boehringer Ingelheim as a reliable partner.

Dr. Isabelle Buschulte & Dr. Dr. Frederik Grünenfelder

Global Rabies Initiative

“Rabies is a fatal zoonotic viral disease transmitted from animals to humans. The World Health Organization (WHO) lists rabies as one of the world’s most deadly infectious diseases. Worldwide, one person every 10 minutes dies because of rabies, 40% of whom are children. Most of the affected live in low income countries.”

With vaccination in dogs serving as the best available defense against its spread, Isabelle Buschulte and Fredrik Grünenfelder from Boehringer Ingelheim started a rabies vaccination project in Nepal in 2019. Through this, they are doing an important part in reaching the WHO’s goal of eliminating all human rabies cases by 2030.

Mukul Bhola

Defeat-NCD Partnership

The Defeat-NCD Partnership, a public-private partnership anchored in the United Nations, is a bold response to the United Nations Sustainable Development Goals: By 2030, reduce by one third premature mortality from non-communicable diseases (NCDs) through prevention and treatment and promote mental health and well-being.

“I am humbled and excited by the opportunity to lead the Defeat-NCD Partnership as its CEO and work together with committed partners like Boehringer Ingelheim. We tackle NCDs – the biggest killer of our age. Furthermore we improve access and affordability to quality healthcare across our 90 plus priority low-resource countries, so that all people with NCDs have the chance to lead a healthy and productive life.”

Germano Garrido

Semear Institute, “Young Seeds” Initiative

“With only 15 percent of Brazilians graduating with a higher educational degree, offering access to education is a major need in Brazil. Non-graduates are far more likely to be caught in the poverty trap: low income, child labor, poor education, low productivity, and repeat.”

To help young people break out of this cycle, Germano and the Semear Institute are partnering with Boehringer Ingelheim to find, support, and recruit some of the best students from the poorer areas of Brazil. Boehringer Ingelheim helps nurture “Young Seeds” through scholarship, mentoring, and networking, so they can grow and become a permanent positive influence on their community.

Isadore Day


“In Canada and around the world, indigenous populations face unique challenges when it comes to battling non-communicable diseases. Ineffective or culturally inappropriate healthcare solutions were being enforced in the past. An outcome-driven action plan has to work with local specificities, providing services ‘Beyond the Pill,’ and establishing sustainable partnerships with indigenous healthcare experts.”

Boehringer Ingelheim has engaged with “Bimaadzwin”, a Canadian indigenous organization that brings First Nation communities and governments together to build an indigenous health policy framework.

Femke Smeets

“Tiba Yako”: integrated disease service model through mobile phone

The “Tiba Yako” app enhances access to healthcare for low-income people in Kenya. The mobile-based technology allows patients to monitor their blood pressure and blood glucose levels at home, digitally send the results to their doctor, get treatment advice, medication prescription, and receive and pay money for medical treatment through a mobile health wallet. In 2019, the app was launched by Boehringer Ingelheim and PharmAccess, a non-profit organization that works to improve access to quality healthcare in Africa. The integrated disease service model offers benefits to patients, healthcare providers, and payers alike.

Dr. Jeremiah Laktabai


“Helping people means so much more than medical treatment. It’s only when we combine care with nutrition and family support, education, counseling, health insurance, food and income security, and self-sufficiency, that we truly change lives for the better.”

Chronic disease is a fast-growing problem in sub-Saharan Africa. “Ampath” healthcare workers in Kenya educate group members on health behaviors and conduct screenings for diabetes and hypertension – helping them prioritize and afford the care they need. As of end of 2019, 70,000 people have been screened in Western Kenya. Boehringer Ingelheim has been partnering with “Ampath” since January 2019.